OpenVSafe by OpenVAERS
Search V-safe

Y5V-10385-44479

3 vaccinations 4 coded responses 24 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
954 / CA
Registered
2020-12-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Registered in v-safe
  2. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-21
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-28
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-01-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  8. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-15
    Survey response — day 35, dose 2
    MedDRA: Pre-eclampsia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Postpartum preeclampsia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-15
    Report sent to call center — day 35, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-02-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-12
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-04
  20. 2021-05-05
  21. 2021-05-06
  22. 2021-05-14
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  23. 2021-07-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-09-21
    Dose 3 — Pfizer-BioNTech
  25. 2021-09-28
    Survey response — day 7, dose 3
    MedDRA: Fatigue, Myalgia — Feeling: Good · Headache · Be unable to do your normal daily activities
    Free text: On 9/22, the day after my vaccine, terrible myalgias and fatigue. Only lasted that day. None since.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-10-07
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-10-12
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  28. 2021-10-21
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-10-26
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-11-02
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-12-21
    Survey response — 3 months, dose 3
    MedDRA: Respiratory syncytial virus infection, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school
    Free text: RSV URI 2 weeks ago. COVID test negative.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-03-22
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-09-21
    Survey response — 12 months, dose 3
    MedDRA: Cardiomyopathy, Office visit, Ventricular extrasystoles — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Frequent PVCs and a mild cardiomyopathy (EF 50%). Had to see a cardiologist and start medications. That was end of May and early June 2022.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-09-21
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  35. 2022-09-22

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-11Pfizer-BioNTech
32021-09-21Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-02-15 Successful
2021-05-14
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-09-21 Unsuccessful

Free text

Release 4 — day 35, dose 2

2021-02-15

Symptoms: Postpartum preeclampsia

Release 9 — day 7, dose 3

2021-09-28

Systemic reaction (other): On 9/22, the day after my vaccine, terrible myalgias and fatigue. Only lasted that day. None since.

Release 10 — 3 months, dose 3

2021-12-21

Symptoms: RSV URI 2 weeks ago. COVID test negative.

Release 12 — 12 months, dose 3

2022-09-21

Symptoms: Frequent PVCs and a mild cardiomyopathy (EF 50%). Had to see a cardiologist and start medications. That was end of May and early June 2022.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCardiomyopathy · · ✓
SDOffice visit · · ✓
SDPre-eclampsia ✓ ✓ ✓
SDRespiratory syncytial virus infection · · ✓
SDSARS-CoV-2 test negative · · ✓
SDUpper respiratory tract infection · · ✓
SDVentricular extrasystoles · · ✓
SROFatigue · · ✓
SROMyalgia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release